Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
276 participants
OBSERVATIONAL
2013-03-31
2016-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Efficiency of Colon Capsule Endoscopy in Colon Cancer Screening
NCT03052335
Efficacy of Colonoscopy, Colon Capsule and Fecal Immunological Test for Colorectal Cancer Screening
NCT02738359
Uptake to Colorectal Cancer Screening in Familial-risk Population
NCT02567045
Personalized Screening Plans to Increase Colorectal Cancer Screening in Healthy Participants
NCT00617071
Does the Invitation by the General Practitioner Improve Patients' Participation in Colorectal Cancer Screening?
NCT01279278
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
All participants gave their informed signed consent. Each centre was assigned a unique ID number to distinguish between the locations in which patients were enrolled.
Patients informations were stored under identification number in secure internet database (RedCap) run by The International Clinical Research Center of St. Anne's University Hospital Brno.REDCap is a secure, web-based application designed to support data capture for research studies.
Statistical analysis was done with SAS, ver. 9.3. Descriptive statistics such as absolute and relative frequencies and median with 95 % confidence intervals were used. Differences between the screening and non-screening groups were compared using the Chi-square test or Fisher's exact test (categorical parameters) and Mann-Whitney test (continuous parameters). Results with a p-value \< 0.05 were considered statistically significant
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Screening Group
CRC diagnosed by screening was defined as cancer diagnosed by primary screening colonoscopy, or colonoscopy after a positive immunochemical based faecal occult blood test i(FOBT) in patients without symptoms invited to examination according to the national screening programme policy
No interventions assigned to this group
Non-screening Group
Symptomatic CRC was defined as cancer diagnosed in symptomatic patients.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* mental disorder
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Private practice at Hluboká nad Vltavou
UNKNOWN
Klaudian Hospital Mladá Boleslav
UNKNOWN
Masaryk Hospital Usti nad Labem
OTHER
Brno University Hospital
OTHER
Medic Kral Ltd.
UNKNOWN
Chomutov Hospital
UNKNOWN
Tomas Bata Hospital, Czech Republic
OTHER
Military University Hospital, Prague
OTHER
Frýdek-Místek Hospital
UNKNOWN
The University Hospital Plzeň
UNKNOWN
Vitkovice Hospital
OTHER
Institute for Clinical and Experimental Medicine
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jan Král, MD
M.D.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jan Král, M.D.
Role: PRINCIPAL_INVESTIGATOR
Institute for Clinical and Experimental Medicine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Institute for Clinical and Experimental Medicine
Prague, , Czechia
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
00023001-2015
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.